|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...8687888990919293949596...110111» |
- | azithromycin / Generic mfg.
Trial completion: IPTp in PNG: Intermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New Guinea (clinicaltrials.gov) - Apr 19, 2013
P3, N=2793, Completed, Sponsor: University of Melbourne
Recruiting --> Completed
- Menopur (menotropin) / Ferring
Enrollment change: Gonadotrophin Dosage Using a Threshold Nomogram for Ovulation Induction in WHO Group II Anovulatory Infertility (clinicaltrials.gov) - Apr 17, 2013
P4, N=75, Completed, Sponsor: Rigshospitalet, Denmark
Recruiting --> Completed N=60 --> 75
- Menopur (menotropin) / Ferring
Trial completion: Gonadotrophin Dosage Using a Threshold Nomogram for Ovulation Induction in WHO Group II Anovulatory Infertility (clinicaltrials.gov) - Apr 17, 2013
P4, N=75, Completed, Sponsor: Rigshospitalet, Denmark
N=60 --> 75 Not yet recruiting --> Completed
- New P1/2 trial: OV-AP-ICG-IV: Imaging of Peritoneal Carcinomatosis From Ovarian Carcinoma Patients (clinicaltrials.gov) - Apr 16, 2013
P1/2, N=10, Recruiting, Sponsor: Jules Bordet Institute
- Enrollment open: OV-AP-ICG-IV: Imaging of Peritoneal Carcinomatosis From Ovarian Carcinoma Patients (clinicaltrials.gov) - Apr 16, 2013
P1/2, N=10, Recruiting, Sponsor: Jules Bordet Institute
Not yet recruiting --> Completed Not yet recruiting --> Recruiting
- medroxyprogesterone injection / Generic mfg.
Biomarker, Trial completion, Biopsy: Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer (clinicaltrials.gov) - Apr 16, 2013
P2, N=52, Completed, Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- || New P2/3 trial: Human Chorionic Gonadotrophin in an Antagonist Protocol (clinicaltrials.gov) - Apr 15, 2013
P2/3, N=60, Recruiting, Sponsor: Cairo University
- veliparib (ABT-888) / AbbVie
Enrollment change, Combination therapy, PARP Biomarker, Metastases: Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer (clinicaltrials.gov) - Apr 15, 2013
P1, N=24, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed N=30 --> 24
- topotecan / Generic mfg., carboplatin / Generic mfg., paclitaxel / Generic mfg.
Enrollment change, Metastases: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (clinicaltrials.gov) - Apr 15, 2013
P2, N=3, Completed, Sponsor: Fox Chase Cancer Center
N=30 --> 24 N=28 --> 3
- | New P4 trial: Trichomonas Vaginalis Repeat Infections Among HIV Negative Women (clinicaltrials.gov) - Apr 14, 2013
P4, N=2883, Recruiting, Sponsor: Tulane University Health Sciences Center
- ||| Avastin (bevacizumab) / Roche
Clinical: ENCOURAGE: First Line Ovarian Cancer Treatment - Cohort Study (clinicaltrials.gov) - Apr 14, 2013
P=N/A, N=500, Recruiting, Sponsor: ARCAGY/ GINECO GROUP
- carboplatin / Generic mfg., paclitaxel / Generic mfg.
Enrollment change: Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer Patients (clinicaltrials.gov) - Apr 11, 2013
P1, N=65, Active, not recruiting, Sponsor: Washington University School of Medicine
N=28 --> 3 N=40 --> 65
- New P1 trial: 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients (clinicaltrials.gov) - Apr 11, 2013
P1, N=16, Recruiting, Sponsor: University Medical Centre Groningen
- carboplatin / Generic mfg., paclitaxel / Generic mfg.
Enrollment closed: Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer Patients (clinicaltrials.gov) - Apr 11, 2013
P1, N=65, Active, not recruiting, Sponsor: Washington University School of Medicine
N=40 --> 65 Recruiting --> Active, not recruiting
- Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine) / UniQuest
Trial completion: Vaccine Therapy in Preventing HPV in HIV-Positive Women in India (clinicaltrials.gov) - Apr 11, 2013
P1, N=150, Completed, Sponsor: AIDS Malignancy Clinical Trials Consortium
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- progesterone / Generic mfg.
Enrollment change: SCOR: Sex Steroids, Sleep, and Metabolic Dysfunction in Women (clinicaltrials.gov) - Apr 10, 2013
P=N/A, N=61, Completed, Sponsor: Washington University School of Medicine
Active, not recruiting --> Completed N=200 --> 61
- progesterone / Generic mfg.
Trial completion: SCOR: Sex Steroids, Sleep, and Metabolic Dysfunction in Women (clinicaltrials.gov) - Apr 10, 2013
P=N/A, N=61, Completed, Sponsor: Washington University School of Medicine
N=200 --> 61 Recruiting --> Completed
- Halaven (eribulin mesylate) / Eisai
Enrollment closed, Combination therapy, Surgery, Metastases: Eribulin Mesylate and Gemcitabine Hydrochloride in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by Surgery (clinicaltrials.gov) - Apr 10, 2013
P1, N=45, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
Recruiting --> Completed Recruiting --> Active, not recruiting
- | Trial completion: Optimum Misoprostol Dose Prior to Office Hysteroscopy (clinicaltrials.gov) - Apr 9, 2013
P3, N=132, Completed, Sponsor: Cairo University
Recruiting --> Active, not recruiting Recruiting --> Completed
- cisplatin / Generic mfg.
Trial termination, Surgery: Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the Cervix (clinicaltrials.gov) - Apr 9, 2013
P3, N=0, Terminated, Sponsor: Gynecologic Oncology Group
Recruiting --> Completed Completed --> Terminated
- pegylated liposomal doxorubicin / Generic mfg.
Trial termination: Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix (clinicaltrials.gov) - Apr 9, 2013
P2, N=0, Terminated, Sponsor: Gynecologic Oncology Group
Completed --> Terminated Completed --> Terminated
- Trial termination, Metastases: Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer (clinicaltrials.gov) - Apr 9, 2013
P3, N=0, Terminated, Sponsor: Gynecologic Oncology Group
Completed --> Terminated Completed --> Terminated
- cisplatin / Generic mfg., gemcitabine / Generic mfg.
Trial termination: Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix (clinicaltrials.gov) - Apr 9, 2013
P2, N=0, Terminated, Sponsor: Gynecologic Oncology Group
Completed --> Terminated Completed --> Terminated
- gemcitabine / Generic mfg.
Trial termination: Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix (clinicaltrials.gov) - Apr 9, 2013
P2, N=0, Terminated, Sponsor: Gynecologic Oncology Group
Completed --> Terminated Completed --> Terminated
- Trial termination: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer (clinicaltrials.gov) - Apr 9, 2013
P2, N=0, Terminated, Sponsor: Gynecologic Oncology Group
Completed --> Terminated Completed --> Terminated
- paclitaxel / Generic mfg., docetaxel / Generic mfg.
Trial termination: Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer (clinicaltrials.gov) - Apr 9, 2013
P2, N=0, Terminated, Sponsor: Gynecologic Oncology Group
Completed --> Terminated Completed --> Terminated
- cisplatin / Generic mfg., amifostine / Generic mfg., paclitaxel / Generic mfg.
Trial termination: Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer (clinicaltrials.gov) - Apr 9, 2013
P2, N=0, Terminated, Sponsor: Gynecologic Oncology Group
Completed --> Terminated Completed --> Terminated
- Trial termination: SWOG-G0137: Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer (clinicaltrials.gov) - Apr 9, 2013
P3, N=2108, Terminated, Sponsor: Gynecologic Oncology Group
Completed --> Terminated Completed --> Terminated
- Trial termination: SWOG-G0164: Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer (clinicaltrials.gov) - Apr 9, 2013
P3, N=0, Terminated, Sponsor: Gynecologic Oncology Group
Completed --> Terminated Completed --> Terminated
- Enrollment closed: A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer (clinicaltrials.gov) - Apr 9, 2013
P=N/A, N=600, Active, not recruiting, Sponsor: Memorial Sloan-Kettering Cancer Center
Completed --> Terminated Recruiting --> Active, not recruiting
- ||| carfilzomib / Generic mfg.
P1/2 data: Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma (clinicaltrials.gov) - Apr 9, 2013
P1/2, N=235, Active, not recruiting, Sponsor: Onyx Therapeutics, Inc.
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- sevoflurane / Generic mfg.
Trial completion: Sevoflurane, Propofol, Postoperative Pain (clinicaltrials.gov) - Apr 8, 2013
P4, N=168, Completed, Sponsor: Tampere University Hospital
Recruiting --> Active, not recruiting Recruiting --> Completed
- ||||||| Trial completion: Multi-centre Study to Compare Efficacy and Safety of AFOLIA and Gonal-f in Women for Assisted Reproductive Treatment (clinicaltrials.gov) - Apr 8, 2013
P3, N=410, Completed, Sponsor: Finox AG
Recruiting --> Completed Active, not recruiting --> Completed
- || pilaralisib (SAR245408) / Sanofi
Enrollment change, Combination therapy: Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors (clinicaltrials.gov) - Apr 8, 2013
P1, N=52, Completed, Sponsor: Sanofi
Active, not recruiting --> Completed N=74 --> 52
- ||| pilaralisib (SAR245408) / Sanofi
Trial completion, Combination therapy: Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors (clinicaltrials.gov) - Apr 8, 2013
P1, N=52, Completed, Sponsor: Sanofi
N=74 --> 52 Active, not recruiting --> Completed
- cefazolin / Generic mfg., azithromycin / Generic mfg.
Enrollment open: Comparison Study of Cefazolin Versus Cefazolin Plus Azithromycin Prophylaxis in Post-Cesarean Endometritis (clinicaltrials.gov) - Apr 7, 2013
P4, N=506, Recruiting, Sponsor: University of Missouri, Kansas City
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- metformin / Generic mfg., clomifene citrate / Generic mfg.
Trial withdrawal: Therapy for Infertile PCOS Patients Ovulating Under Clomiphene Citrate or Metformin (clinicaltrials.gov) - Apr 4, 2013
P4, N=0, Withdrawn, Sponsor: University Magna Graecia
Not yet recruiting --> Recruiting Recruiting --> Withdrawn
- Trial suspension: Controlled Ovarian Stimulation Followed by Timed Intercourse or Intrauterine Insemination in Infertile PCOS Patients (clinicaltrials.gov) - Apr 4, 2013
P4, N=100, Suspended, Sponsor: University Magna Graecia
Recruiting --> Withdrawn Recruiting --> Suspended
- | progesterone / Generic mfg.
New P4 trial: Intrauterine Insemination and Luteal Fase Support (clinicaltrials.gov) - Apr 4, 2013
P4, N=198, Enrolling by invitation, Sponsor: Universitaire Ziekenhuizen Leuven
- clomifene citrate / Generic mfg.
Trial withdrawal: Clomiphene Citrate in Infertile PCOS Patients (clinicaltrials.gov) - Apr 4, 2013
P4, N=0, Withdrawn, Sponsor: University Magna Graecia
Recruiting --> Suspended Recruiting --> Withdrawn
- metformin / Generic mfg.
Trial withdrawal: Metformin Administration in Infertile Anovulatory PCOS Patients (clinicaltrials.gov) - Apr 4, 2013
P4, N=0, Withdrawn, Sponsor: University Magna Graecia
Recruiting --> Withdrawn Recruiting --> Withdrawn
- Clinical: VARITI-5 : Study of Variations of Serum ITIH5 in Women During the Genital Life and in Pathological Situations (clinicaltrials.gov) - Apr 4, 2013
P=N/A, N=175, Recruiting, Sponsor: Rennes University Hospital
- Enrollment change: Bacterial Vaginosis in Pregnancy: Detection by Weekly Vaginal pH Testing (clinicaltrials.gov) - Apr 3, 2013
P=N/A, N=1049, Completed, Sponsor: Montse Palacio
Recruiting --> Withdrawn N=3600 --> 1049
- Trial completion: Bacterial Vaginosis in Pregnancy: Detection by Weekly Vaginal pH Testing (clinicaltrials.gov) - Apr 3, 2013
P=N/A, N=1049, Completed, Sponsor: Montse Palacio
N=3600 --> 1049 Recruiting --> Completed
- Sutent (sunitinib) / Pfizer
New P2 trial: Sunitinib (clinicaltrials.gov) - Apr 3, 2013
P2, N=30, Recruiting, Sponsor: Cathay General Hospital
- Trial completion: Using a Sheathed Speculum to Visualize and Access the Cervix In Women With Excessive Vaginal Tissue (clinicaltrials.gov) - Apr 2, 2013
P=N/A, N=38, Completed, Sponsor: University of South Florida
Recruiting --> Completed Recruiting --> Completed
- Trial completion: Research Study for Children With a Mother or Sister With Polycystic Ovary Syndrome (clinicaltrials.gov) - Apr 2, 2013
P=N/A, N=136, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Intrauterine Environment in Polycystic Ovary Syndrome (PCOS) Probands (clinicaltrials.gov) - Apr 2, 2013
P=N/A, N=70, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Cycloset (bromocriptine) / Bausch Health
Enrollment open: Vaginal Bromocriptine for Treatment of Adenomyosis (clinicaltrials.gov) - Apr 2, 2013
P1, N=33, Recruiting, Sponsor: Mayo Clinic
Active, not recruiting --> Completed Active, not recruiting --> Recruiting
- |||| veliparib (ABT-888) / AbbVie
Enrollment open, BRCA Biomarker: Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status (clinicaltrials.gov) - Apr 2, 2013
P1/2, N=80, Recruiting, Sponsor: Vejle Hospital
Active, not recruiting --> Recruiting Not yet recruiting --> Recruiting